Research and Markets: Forecast Insight: Insomnia Orexin and Serotonin Receptor Modulators to...

Dublin - Research and Markets (http://www.researchandmarkets.com/research/0a621a/forecast_insight) has announced the addition of the "Forecast Insight: Insomnia Orexin and Serotonin Receptor Modulators to Innovate Market" report to their offering. After 3 years of steady growth, the value of the insomnia market across the seven major markets (7MM) slumped by 12% to $4.1 billion in 2007 due to rapid generic erosion of Sanofi-Aventiss market leader Ambien (zolpidem) in the US. However, this downturn will be short-lived and the market will regain growth from 2009 to $6.9 billion in 2017 driven by the launch of new treatments across the 7MM. Scope - This report gives a strategic analysis of the likely impact that recent events will have on the future insomnia market - Includes insomnia-specific sales forecasts for the key brands... [read full story]